Markets · 1 sources covering this

Adarx Pharmaceuticals Raises $446.3 Million in Upsized US IPO

Adarx Pharmaceuticals Inc., a late-stage developer of gene therapies, raised $446.3 million in an upsized initial public offering that priced at the top of its marketed range.

Share:X WhatsApp Reddit Facebook LinkedIn Open ↗

Coverage spectrum

1 L · 0 C · 0 R

How 1 sources are covering this

BloombergLean L·2h ago
Adarx Pharmaceuticals Raises $446.3 Million in Upsized US IPO
Adarx Pharmaceuticals Inc., a late-stage developer of gene therapies, raised $446.3 million in an upsized initial public offering that priced at the top of its marketed range.
Read at Bloomberg →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://statesidedaily.com/embed/cluster/6cf6c6ff43fca6b4ad3dd35a943a3b8a6b634d0c"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Adarx Pharmaceuticals Raises $446.3 Million in Upsized US IPO"></iframe>

Adarx Pharmaceuticals Raises $446.3 Million in Upsized US IPO

How 1 sources are covering this

Adarx Pharmaceuticals Raises $446.3 Million in Upsized US IPO

More from Markets

Grains Drop With Trump-Xi Summit Yet to Offer Farm Trade Details

AI Boom Can Withstand Higher Rates: Goldman's Moe

Lula to Ban Online Betting, Offer Debt Relief Before Election

Gold Tilts Lower as Iran Impasse Continues to Fan Rate-Hike Bets

Reader

Trust & legal

Across the network